Members area 
Members area 
Strategy Consulting
We advise private companies, investment funds, non-governmental organizations, and banks on strategic investment, business valuation, and search for acquisition targets within the Life Sciences sectors.
Strategic advisory services in WE, CEE, Ukraine, Central Asia, and South Caucasus
At Eirhub, we specialize in providing comprehensive and multifaceted expertise to our clients in the Life Sciences industry. We deeply understand of the internal processes in healthcare, the supply chain in the pharmaceutical and medical equipment/devices markets, and the business models specific to our region. By partnering with our clients, we deliver various services to meet their unique needs.
We provide full support to institutional investors assessing targets in Pharma, MedTech, Digital Health, and Healthcare sectors. Our professionals offer market analysis, competitor research, and strategic recommendations to enhance situational awareness and drive growth. We also conduct regulatory compliance assessments and evaluate supply chain elements to help clients make informed investment decisions that maximize returns and mitigate risks.
With extensive expertise in due diligences within the pharmaceutical, healthcare, biotechnology, and medical technology industries, we support buyers and sellers of companies or company shares, including private equity firms, business angels, multinational corporations, and owner-managed niche champions.
At Eirhub we specialize in M&A services for the Life Sciences sector, using our extensive knowledge and experience in collaborating with investors such as family offices and PEFs. We provide guidance to help investors navigate the unique complexities of the region.
We leverage our international experiences, analytical methods, and industry-specific know-how to develop promising strategies for our clients looking to expand into regions we cover: EU, Eurasia, Ukraine, China, and India.
Consulting & Strategy project examples:
Pre-Investment Due Diligence: An independent assessment of the investment project to help the Client in assessing risks of investing in the local pharmaceutical manufacturer. Client: pan-European investment institution. More details >>
Commercial and Marketing Due Diligence: A complex assignment to research Target's core and potential markets, incl. assessment of the sustainability of demand for locally produced drugs in the region, evaluation of marketing strategy, financial and business model. More details >>
General Due Diligence: Assessment of investment risks and provision of an independent opinion on Target's core business areas, incl. its product development process and in-house research and development (R&D) capacity to develop new original and generic products. More details >>
Opportunity Assessment: Analysis of existing markets for the portfolio of recently acquired products. Assessment of a possible synergy effect from complimenting existing Client's portfolio to a recently acquired set of products. More details >>
Feasibility Study for a New Business: A detailed assessment of a potential entry into a country with a new legal entity and a set of established branded generics portfolio. Marketing planning and Organizational modelling. More details >>
Market Entry Pathways Research: Development of market entry roadmap for an innovative neurology product. Analysis of competition, possible pricing strategies, and study of the readiness to prescribe among physicians.More details >>
Practice Leaders
Yevgen Brovko
Co-founder, Market Access Partner (Pharmac/Biopharma, MedTech, Digital Health)
Martin Schloh, Ph.D.
Associate Partner, Strategy Consulting (Pharma & MedTech)
Anastasiia Maksymenko
Co-founder, Recruitment Partner (Pharma, Biotechnology, MedTech, Healthcare)
RFP
Send us your Request For Proposal
Case Studies
Download
our Brochure
our Brochure